Roxana Mehran, MD, FACC
President

Roxana Mehran, MD, FACC, is an endowed professor of cardiovascular clinical research and outcomes and a professor of medicine (cardiology) and population health science and policy at the Icahn School of Medicine at Mount Sinai. Mehran completed fellowships in cardiovascular disease and interventional cardiology at Mount Sinai Medical Center, where she was also named Director of the Women's Heart and Vascular Center at Mount Sinai Fuster Heart Hospital, spearheading a program designed to meet the unique needs of women's cardiovascular health.

Mehran has served as principal investigator for numerous global studies, developed risk scores for bleeding and acute kidney injury, participated in development of clinical guidelines and authored more than 2,000 peer-reviewed articles. She is also leading the Lancet Commission on Women's Cardiovascular Diseases. With over 2,300 published manuscripts, Mehran was named by Clarivate Analytics as one of the most influential scientific minds in their Highly Cited Researchers list for the past eight years. She is a founder and Chief Scientific Officer of the Cardiovascular Research Foundation and the founder of Women as One.

At the ACC, Mehran has served as Chair of the Interventional Section Leadership Council and has been an author on several revascularization and dual antiplatelet therapy guidelines. She has also been active in the Society for Cardiovascular Angiography and Interventions, where she served as Program Chair of the 2016 Scientific Sessions and co‑founded the Women in Innovations Committee.

Mehran's honors include the 2017 ACC Bernadine Healy Leadership in CV Disease Award, the 2018 Nanette Wenger Award for Excellence in Medical Leadership from WomenHeart, the Ellis Island Medal of Honor (2019) and the ESC Silver Medal with the Andreas Grüntzig Lecture (2019). In 2022 she received the Terry Ann Krulwich Physician-Scientist Alumni Award, PulseSetter Champion Award and AHA Women in Cardiology Mentoring Award; in 2023, she received the ACC Bahr Award of Excellence.

Hani K. Najm, MD, FACC
Vice President

Hani K. Najm, MD, FACC, was born and educated in Riyadh, Saudi Arabia, where he demonstrated outstanding academic performance throughout his early education. He graduated from King Saud University Medical School in 1985, followed by advanced training in general surgery, cardiothoracic surgery and pediatric congenital heart surgery in Canada. In 1999, he returned to Riyadh and spent 17 years developing one of the premier pediatric heart centers at King Abdulaziz Medical Center.

Najm was recruited to Cleveland Clinic and joined on Jan. 1, 2016, as chair of Pediatric and Adult Congenital Heart Surgery. He is widely regarded as a global expert in congenital heart surgery, having performed more than 12,000 surgical procedures on newborns, children and adults with congenital heart disease.

He is known for pioneering innovations that have advanced the field, including development of a patented growing heart valve for children, a first‑of‑its‑kind intrauterine resection of a malignant fetal cardiac tumor, and a novel surgical approach that avoids heart transplantation in children with complex congenital heart disease (pulmonary atresia/intact ventricular septum with right ventricular–dependent coronary circulation).

In 2024, he was named the first recipient of the Great Arab Minds Award, recognizing his groundbreaking contributions to pediatric and adult cardiac surgery. He is a frequent international speaker and collaborator in global research initiatives focused on improving outcomes in congenital heart disease.

Najm is a professor of surgery at Case Western Reserve University and has authored more than 200 peer‑reviewed publications.

His contributions extend beyond clinical excellence. He is a past president of the Saudi Heart Association, former editor‑in‑chief of the Journal of the Saudi Heart Association, a member of the editorial board of the Saudi Medical Journal, and an associate professor at King Abdulaziz University for Health Sciences. He has also been actively involved in international research collaborations, including multicenter databases advancing evidence‑based care in congenital heart disease.

Najm holds a black belt 5th Dan in taekwondo and is a three‑time gold medal champion in the welterweight division in Saudi Arabia. He also served as president of the Saudi Taekwondo and Judo Federation.

An internationally recognized lecturer and thought leader, Najm continues to shape the future of congenital heart surgery through innovation, education and global collaboration.

Christopher M. Kramer, MD, MACC
Immediate Past President

Christopher M. Kramer, MD, MACC, received his medical degree from UCSF School of Medicine and completed residency, chief residency and cardiology fellowship at the Hospital of the University of Pennsylvania. He held early faculty roles at Allegheny General Hospital and MCP Hahnemann University School of Medicine, where he directed the cardiology fellowship, before moving to the University of Virginia School of Medicine. In 2019 he was named the George A. Beller/Lantheus Medical Imaging Distinguished Professor of Cardiovascular Medicine, Chief of the Division of Cardiovascular Medicine, and Medical Director of the Heart and Vascular Science Line.

Kramer's principal research interest is cardiovascular magnetic resonance, spanning studies from mice to humans. He has served as President of the Society for Cardiovascular Magnetic Resonance, Chair of the NIH Clinical and Integrative Cardiovascular Sciences study section, ACC Treasurer and Chair of ACC's Imaging Council. He is an associate editor at JACC and previously was Executive Editor of JACC: Cardiovascular Imaging; he serves on the editorial boards of Circulation, Circulation: Cardiovascular Imaging and Vascular Medicine. Honors include the SCMR Gold Medal (2015) and the ACC Distinguished Mentor Award (2021).

Akshay K. Khandelwal, MD, MBA, FACC
ACC Treasurer
2024-2027

Akshay K. Khandelwal, MD, MBA, FACC, is System Chair for the Department of Cardiovascular Medicine at Allegheny Health Network, providing strategic and operational oversight for ~90 cardiologists, 60 advanced practice providers and 23 fellows in training across an 11-hospital system. He trained at Henry Ford Hospital (residency, chief residency, cardiology and interventional fellowships) and earned an MBA from the University of Tennessee.

Before joining Allegheny Health Network, he served as Associate Medical Director for the Heart and Vascular Service Line at Henry Ford Hospital, sat on the Mosaic ACO Board and chaired Michigan's STEMI Systems of Care Task Force. A clinician-educator focused on complex PCI, STEMI systems, and critical care cardiology, he has ~50 publications in cardiogenic shock, ACS and PCI.

Within ACC he has served as Chair of the Board of Governors; Secretary of the Board of Trustees; President/Governor, Michigan Chapter; member, Annual Scientific Session Program Committee; Chair, Digital Transformation Task Force; member, Health Equity Task Force; Chair, Investment Subcommittee; and member, Finance Committee. He currently serves as Chair of Finance and Treasurer.

Renuka Jain, MD, FACC
Secretary and Board of Governors Chair

Renuka Jain, MD, FACC, is an interventional echocardiographer at Aurora St. Luke's Medical Center in Milwaukee, WI. She serves as Director of Echocardiography for the Advocate Aurora Health Midwest Region and is an adjunct clinical associate professor at the University of Wisconsin School of Medicine and Public Health. Her research focuses on valvular heart disease and structural heart interventions.

Jain received her medical degree from Columbia University and completed internal medicine residency at New York-Presbyterian Hospital, followed by cardiology fellowship at the University of Michigan Hospitals. She is the current ACC Governor for Wisconsin, an associate editor of Structural Heart Journal, and serves on the editorial boards of JACC: Case Reports and the Journal of the American Society of Echocardiography.

Dinesh Kalra, MD, FACC
Board of Governors Chair-Elect

Dinesh Kalra, MD, FACC, is Chief of Cardiology at the University of Louisville (UofL) Medical Center in Louisville, KY, and is a tenured professor of medicine and radiology at the UofL School of Medicine. He also serves as Vice Chair for Quality in the Department of Medicine. At UofL Hospital, he is on the Board of Directors, Chair of the Quality Assurance Committee for Cardiology, and serves as the Director of the Heart Board for the Cardiovascular Service Line. He holds an Endowed Chair position in the Jewish Hospital Cardiovascular Innovation Institute and serves as the Governor of the Kentucky chapter of the ACC. Kalra is an international expert in multimodality cardiac imaging, as well as preventive cardiology and lipidology. His clinical and research interests are in coronary plaque regression, cardiac CT and MR, population-based health and AI, complex dyslipidemias, infiltrative cardiomyopathies such as Fabry, amyloid, sarcoid, and pulmonary hypertension.

He is board-certified in Cardiology, Echocardiography, CT, CMR, Lipidology and Nuclear Cardiology. He is also a member of the education committees for the Society for Cardiovascular Magnetic Resonance (SCMR) and Society for Cardiovascular Computed Tomography (SCCT) and on the Joint Performance Committee, Scientific Publications committee, and the Research Committee for the ACC and American Heart Association (AHA). He also serves on the National Lipid Association Publications Committee and Science Committees. He is a member of the National Quality Forum in Washington, DC. Kalra has published over 300 scholarly articles (H-index of 48), many abstracts and book chapters, and has lectured internationally on lipids, cardiac imaging, plaque regression, Fabry and Amyloid. He is a consultant for JACC , and is an associate editor for the Journal of Clinical Lipidology, the American Journal of Preventive Cardiology, and the Journal of Clinical Medicine, and is on the editorial boards of several other journals.

Kalra has consistently ranked on the "Top 100 Doctors" list and is recognized for his excellence in Cardiology by Crain's Business Review and Castle Connolly. The ACC awarded the 2025 Gifted Educator Award to Kalra for his exemplary teaching and mentoring skills. He also received the Best Faculty Award from UofL fellows for 2023, 2024 and 2025, and the Kentucky Medical Association Educational Achievement Award in 2025.

Lee R. Goldberg, MD, MPH, FACC
Trustee

Lee R. Goldberg, MD, MPH, FACC, is Professor of Medicine at the Perelman School of Medicine and Chief of the Advanced Heart Failure and Transplant Section at the University of Pennsylvania. As Vice Chair of Medicine for Informatics, he oversees EMR implementation/optimization, data coordination across the Department of Medicine, and clinician wellness initiatives.

He earned his MD cum laude from Boston University, completed internal medicine at the Hospital of the University of Pennsylvania, and fellowships in cardiovascular disease and advanced heart failure/transplantation at Massachusetts General Hospital/Harvard Medical School. He also holds an MPH in Clinical Effectiveness from the Harvard School of Public Health.

Goldberg's research includes heart failure disease management, remote monitoring, sleep-CV interactions, telemedicine, and leveraging big data for outcomes and clinician effectiveness, with AHRQ/NIH-funded work. Within ACC, he has served as Chair of the Member Section Steering Committee and of the Heart Failure & Cardiac Transplant Leadership Council; he currently serves on the Audit & Compliance Committee and the BOT Task Force on Clinician Well-Being and is Deputy Editor for the CMP for Advanced Heart Failure Evaluative Question Writing Committee.

Samuel O. Jones IV, MD, MPH, FACC
Trustee

Samuel O. Jones, MD, MPH, FACC, is Director of Inpatient Electrophysiology at the Memorial Hospital for Chattanooga Heart Institute. He is Past Chair of the ACC Health Affairs Committee and previously co-led the Electrophysiology Service Line for Common-Spirit. He also serves on the Board of Trustees for the Chattanooga Medical Society.

Board-certified in Cardiovascular Diseases and Clinical Cardiac Electrophysiology, Jones is a Fellow of the ACC and the Heart Rhythm Society. A retired U.S. Air Force Colonel, he served as Associate Professor of Medicine at the Uniformed Services University, faculty for the cardiology fellowship for a decade, Cardiology Consultant and Chief Consultant of Internal Medicine to the Air Force Surgeon General, and as an F-15 flight surgeon.

He completed clinical cardiac EP fellowship at Brigham and Women's Hospital while earning an MPH from the Harvard School of Public Health and completed cardiovascular fellowship at Lackland AFB. His professional interests include Sports Cardiology and sudden cardiac death. Within ACC, he has chaired the Federal Cardiology Section and served on the NCDR Oversight Committee, Board of Governors (2012–2015) and Tennessee Chapter Council (2018–present).

Fred M. Kusumoto, MD, FACC
Trustee

Fred M. Kusumoto, MD, FACC, is Professor of Medicine, Associate Dean of Faculty Affairs for the Mayo Clinic Alix School of Medicine (Florida campus) and Chair of the Heart Rhythm Division at Mayo Clinic Florida. He is the current Clinical Editor-in-Chief for ACC.org. He has chaired the Heart Rhythm Society's Health Policy Committee, among others, and is a past president of HRS. He is a past Governor of the ACC Florida Chapter and has served as Chair for the ACC Scientific Publications Committee and the NCDR LAAO Registry Steering Committee, and Co-Chair of the ACC Asia conference.

He has chaired or led several major societal documents, including: the 2018 ACC/AHA/HRS Bradycardia and Conduction Disorders Guideline; the 2017 ACC/AHA/HRS Sudden Cardiac Death and Ventricular Arrhythmias Guideline Evidence Review Committee; the 2017 HRS Expert Consensus Statement on Lead Management and Extraction; and the 2014 HRS/ACC/AHA Expert Consensus Statement on ICD Therapy in Patients Not Included or Not Well Represented in Clinical Trials.

Bonnie Ky, MD, MSCE, FACC
Trustee

Bonnie Ky, MD, MSCE, FACC, is the Founder's Professor of CardioOncology and a physician-scientist at the University of Pennsylvania. She directs a robust NIH and AHA-funded clinical translational research program aimed at improving cardiovascular care for patients with cancer. She is Director of the Thalheimer Center for Cardio-Oncology, Founding Director of the Penn Translational Cardio-Oncology Center of Excellence and Director of the Penn Center for Quantitative Echocardiography.

Ky chairs the NIH Clinical Integrative Cardiovascular and Hematological Sciences Study Section and the ECOG-ACRIN Cardiotoxicity subcommittee, and serves on multiple national and international consensus groups (NIH, FDA, ASCO, ACC, AHA, ESC). She is the inaugural Editor-in-Chief of JACC: CardioOncology, a member of the American Society for Clinical Investigation and the Association of American Physicians, and recipient of the ICOS Thomas Force Leadership Award and the ECOG-ACRIN Young Investigator Award.

Sandra J. Lewis, MD, FACC
Trustee

Sandra J. Lewis, MD, FACC, practices cardiology at Legacy Health in Portland, Oregon, where she led a multispecialty cardiology group for 25 years. She is past Governor of the ACC Oregon Chapter; past Chair of the ACC Section Steering Committee, HeartPAC, Women in Cardiology Section, and Ethics & Compliance Committee; and a member of the Health Affairs Committee. She founded the SJL Mid-Career Women's Leadership Institute.

A Stanford graduate (MD, residency, fellowship), Lewis has been an investigator in landmark trials (SAVE, PROVE-IT, TNT, JUPITER, CARE) and has authored/co-authored multiple ACC professional life and women's cardiovascular health papers. She has been recognized on "America's Top Doctors" lists and as one of Good Housekeeping's top cardiac doctors for women.

Pamela B. Morris, MD, FACC
Trustee

Pamela B. Morris, MD, FACC, is Professor of Medicine in Cardiology, the Paul V. Kramer Chair of Cardiovascular Disease Prevention, and Director of the Seinsheimer Cardiovascular Health Program at MUSC. She trained at Duke, where she served as Medical Director of the Duke Center for Living/Preventive Cardiology, and later served at Mayo Clinic before joining MUSC.

A leader in preventive cardiology, Morris coauthored multiple ACC Expert Consensus Decision Pathways and served as Vice Chair of ACC.19/ACC.20 and Chair of ACC.21/ACC.22. She received the inaugural ACC Excellence in Leadership Award (Heart House Roundtable methodology), the National Lipid Association Clinician Educator Award (2020) and the ACC Distinguished Service Award (2023). She has held leadership roles across the National Lipid Association, American Society of Preventive Cardiology, ABCL and SCCT, and cofounded ACC's Heart House Roundtable methodology.

Andrea L. Price, MS, CPHQ, FACC
Trustee

Andrea L. Price, MS, CPHQ, FACC, is the Senior Director of the Ascension Data Science Institute (ADSI) at Ascension, a leading nonprofit Catholic health system, where she leads strategic support and oversight for clinical research, ambulatory quality and population health analytics teams. Previously, she held several leadership roles at Indiana University Health overseeing clinical registry operations and population health initiatives. Price began her health care career as a cardiovascular technologist in the cardiac catheterization lab. She earned both her undergraduate and graduate degrees from Indiana State University.

Price has held multiple leadership roles within the ACC, including Chair of the Cardiovascular Team Section Leadership Council (2022–2025) and Chair of the ACC's Reduce the Risk: PCI Bleeding Campaign (2018–2021). She currently serves on the HeartPAC Executive Committee.

A recognized health care quality professional, Price is known for expertise in quality data management, implementation science, and driving improvements in process, quality and organizational performance. Her contributions have earned several accolades, including the NCDR Conference People's Choice Award (2014), the IU Health Values Leadership Award (2020) and the ACC Distinguished Cardiovascular Team Member Award (2024). She was also a recipient of the inaugural ACC Foundation Quality Initiative Grant in 2018.

Geoffrey A. Rose, MD, FACC
Trustee

Geoffrey A. Rose, MD, FACC, is the Jerome & Rosalind Richardson Endowed Chair in Cardiovascular Medicine and Professor of Medicine at Wake Forest University School of Medicine; President, Sanger Heart & Vascular Institute; and Heart & Vascular Service Line Leader, Advocate Health Southeast Region.

A Fellow of the ACC and the American Society of Echocardiography (ASE), Rose served as Program Chair for the ASE 2017 Scientific Sessions and on the ASE Board of Directors, and is the ASE representative to the AMA RUC. He is former President of the Intersocietal Accreditation Commission, Course Co-Director for the ACC Cardiovascular Summit, Chair of the ACC Partners in Quality Subcommittee, and an inaugural member of the Board of Managers for ACC MedAxiom.

Rose is a graduate of the University of Pennsylvania School of Medicine; he completed internal medicine at the Hospital of the University of Pennsylvania (Chief Resident) and cardiovascular training at Massachusetts General Hospital, including a research fellowship in echocardiography.

Andreas Merkl, MBA
Public Member Trustee

Andreas Merkl, MBA, is the CEO and co-founder of Centigrade, a data company focused on global carbon and nature credit markets. He is also a research fellow at Oxford University. Most of his life's work has centered on complex systems problems on the human/ecology interface, including climate, oceans, circular economy/plastic, food systems and natural resource management. Merkl holds a master's degree in business administration from Harvard University ; a master's degree in City and Regional Planning from the University of California, Berkeley ; and a bachelor's degree from the University of California, Santa Cruz in Natural History and Environmental Studies.

Merkl learned politics working for Diane Feinstein in San Francisco, CA. He spent the better part of a decade with McKinsey & Coin banking and natural resources. From 2000 through 2013, he grew CEA, a San Francisco-based consulting and investment platform, into an incubator of environmental foundations. He has also held senior management or governance roles at an international treaty-based organization (Global Green Growth Institute), venture capital funds (e.g. SeaChange Fund), industry associations (e.g. Chemical Recycling Partnership), a fiscal sponsorship organization (e.g. The Canopy Institute, now Multiplier) and non-profits (e.g. Community Conservation Investment Forum). From 2013 through 2018, Andreas was the CEO of the Ocean Conservancy.

Most recently, Merkl was the lead author on the High-Level Panel on Sustainable Ocean Economies Report, worked with a major global investor on reshaping global plastics recycling markets, and served as a principal in the Finance for Biodiversity initiative. He has a long-term collaboration with Oxford University on quantitative assessments of the dynamics between complex ecological systems, their users and the polices that govern them. He chairs Sustain our Urban Landscape (SOUL), a non-profit focused on the reforestation of New Orleans, LA.